BIOENGSOL
ActiveSummary
BIOENGSOL has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €192,476 and a net result of €91,239. Its solvency ranks better than 95% of 39,200 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
10-06
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial
Liquidity more than 5 timescurrent ratio 39.96
Current ratio from 7.43 to 39.96; short-term debt falls from €15,742 to €4,930.
31-12
Financial
Equity above €150,000equity €192,476 ▲90.1%
A profit in every financial year since 2024 builds equity to €192,476.
07-07
NBB filing
Annual accounts filed
financial year 2024 · micro format
2023
19-12
Gazette deed
IncorporationAppointment: CAULIER Simon Pierre (director) · Founder · Capital10 facts ▸
Gazette deed
Incorporation
Appointment: CAULIER Simon Pierre (director) · Founder · Capital10 facts ▸
- Incorporation, 15-12-2023
- Founder, CAULIER Simon Pierre
- Other provision, “avertissement fondateurs et plan financier, article 5:16,2° du Code des Sociétés et des Associations” (deed in French)
- Capital
- Founding capital
- Founder, CAULIER Simon Pierre (souscripteur)
- Bank account, “société en formation, BE44 0689 5076 6745” (deed in French)
- Board rule, 1, “L'ORGANE D'ADMINISTRATION” (deed in French)
- Director appointment, CAULIER Simon Pierre (director (not named in the articles))
- Registered office clause, “7040 Quévy(Quévy-le-Petit),rue de Frameries,2, ADRESSE DU SIEGE” (deed in French)
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 1 deed read